184 related articles for article (PubMed ID: 25412253)
21. Chitosan nanoparticles as a potential drug delivery system for the ocular surface: toxicity, uptake mechanism and in vivo tolerance.
Enríquez de Salamanca A; Diebold Y; Calonge M; García-Vazquez C; Callejo S; Vila A; Alonso MJ
Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1416-25. PubMed ID: 16565375
[TBL] [Abstract][Full Text] [Related]
22. Preparation, characterization, and evaluation of gatifloxacin loaded solid lipid nanoparticles as colloidal ocular drug delivery system.
Kalam MA; Sultana Y; Ali A; Aqil M; Mishra AK; Chuttani K
J Drug Target; 2010 Apr; 18(3):191-204. PubMed ID: 19839712
[TBL] [Abstract][Full Text] [Related]
23. Further investigation of nanostructured lipid carriers as an ocular delivery system: in vivo transcorneal mechanism and in vitro release study.
Tian BC; Zhang WJ; Xu HM; Hao MX; Liu YB; Yang XG; Pan WS; Liu XH
Colloids Surf B Biointerfaces; 2013 Feb; 102():251-6. PubMed ID: 23006566
[TBL] [Abstract][Full Text] [Related]
24. Microfluidic directed self-assembly of liposome-hydrogel hybrid nanoparticles.
Hong JS; Stavis SM; DePaoli Lacerda SH; Locascio LE; Raghavan SR; Gaitan M
Langmuir; 2010 Jul; 26(13):11581-8. PubMed ID: 20429539
[TBL] [Abstract][Full Text] [Related]
25. Understanding the influence of surface properties of nanoparticles and penetration enhancers for improving bioavailability in eye tissues in vivo.
Mahaling B; Katti DS
Int J Pharm; 2016 Mar; 501(1-2):1-9. PubMed ID: 26821059
[TBL] [Abstract][Full Text] [Related]
26. Novel ultra-small micelles based on rebaudioside A: A potential nanoplatform for ocular drug delivery.
Song K; Xin M; Yu H; Zheng Z; Li J; Li M; Guo H; Tan Y; Wu X
Int J Pharm; 2018 Dec; 552(1-2):265-276. PubMed ID: 30291959
[TBL] [Abstract][Full Text] [Related]
27. Lipid nanoparticles (SLN, NLC): Overcoming the anatomical and physiological barriers of the eye - Part I - Barriers and determining factors in ocular delivery.
Sánchez-López E; Espina M; Doktorovova S; Souto EB; García ML
Eur J Pharm Biopharm; 2017 Jan; 110():70-75. PubMed ID: 27789358
[TBL] [Abstract][Full Text] [Related]
28. Preparation and characterization of ascorbic acid loaded solid lipid nanoparticles and investigation of their apoptotic effects.
Güney G; Kutlu HM; Genç L
Colloids Surf B Biointerfaces; 2014 Sep; 121():270-80. PubMed ID: 24985762
[TBL] [Abstract][Full Text] [Related]
29. Preparation and characterization of teniposide PLGA nanoparticles and their uptake in human glioblastoma U87MG cells.
Mo L; Hou L; Guo D; Xiao X; Mao P; Yang X
Int J Pharm; 2012 Oct; 436(1-2):815-24. PubMed ID: 22846410
[TBL] [Abstract][Full Text] [Related]
30. Nanostructured lipid carrier versus solid lipid nanoparticles of simvastatin: comparative analysis of characteristics, pharmacokinetics and tissue uptake.
Tiwari R; Pathak K
Int J Pharm; 2011 Aug; 415(1-2):232-43. PubMed ID: 21640809
[TBL] [Abstract][Full Text] [Related]
31. Novel 'nano in nano' composites for sustained drug delivery: biodegradable nanoparticles encapsulated into nanofiber non-wovens.
Beck-Broichsitter M; Thieme M; Nguyen J; Schmehl T; Gessler T; Seeger W; Agarwal S; Greiner A; Kissel T
Macromol Biosci; 2010 Dec; 10(12):1527-35. PubMed ID: 20824691
[TBL] [Abstract][Full Text] [Related]
32. Analysis of interactions between the corneal epithelium and liposomes: qualitative and quantitative fluorescence studies of a corneal epithelial cell line.
Pleyer U; Grammer J; Kosmidis P; Ruckert DG
Surv Ophthalmol; 1995 May; 39 Suppl 1():S3-16. PubMed ID: 7660310
[TBL] [Abstract][Full Text] [Related]
33. Self-reporter shikonin-Act-loaded solid lipid nanoparticle: formulation, physicochemical characterization and geno/cytotoxicity evaluation.
Eskandani M; Nazemiyeh H
Eur J Pharm Sci; 2014 Aug; 59():49-57. PubMed ID: 24768857
[TBL] [Abstract][Full Text] [Related]
34. Skin Localization of Lipid Nanoparticles (SLN/NLC): Focusing the Influence of Formulation Parameters.
Amasya G; Sandri G; Onay-Besikci A; Badilli U; Caramella C; Bonferoni MC; Tarimci N
Curr Drug Deliv; 2016; 13(7):1100-1110. PubMed ID: 26725723
[TBL] [Abstract][Full Text] [Related]
35. The evidence for solid lipid nanoparticles mediated cell uptake of resveratrol.
Teskac K; Kristl J
Int J Pharm; 2010 May; 390(1):61-9. PubMed ID: 19833178
[TBL] [Abstract][Full Text] [Related]
36. Rheological and in vitro release behaviour of clotrimazole-containing aqueous SLN dispersions and commercial creams.
Souto EB; Müller RH
Pharmazie; 2007 Jul; 62(7):505-9. PubMed ID: 17718190
[TBL] [Abstract][Full Text] [Related]
37. Lipid nanoparticles: effect on bioavailability and pharmacokinetic changes.
Souto EB; Müller RH
Handb Exp Pharmacol; 2010; (197):115-41. PubMed ID: 20217528
[TBL] [Abstract][Full Text] [Related]
38. Solid lipid nanoparticles for ocular drug delivery.
Seyfoddin A; Shaw J; Al-Kassas R
Drug Deliv; 2010; 17(7):467-89. PubMed ID: 20491540
[TBL] [Abstract][Full Text] [Related]
39. Topical Formulation of Self-Assembled Antiviral Prodrug Nanomicelles for Targeted Retinal Delivery.
Mandal A; Cholkar K; Khurana V; Shah A; Agrahari V; Bisht R; Pal D; Mitra AK
Mol Pharm; 2017 Jun; 14(6):2056-2069. PubMed ID: 28471177
[TBL] [Abstract][Full Text] [Related]
40. Long-term stability, biocompatibility and oral delivery potential of risperidone-loaded solid lipid nanoparticles.
Silva AC; Kumar A; Wild W; Ferreira D; Santos D; Forbes B
Int J Pharm; 2012 Oct; 436(1-2):798-805. PubMed ID: 22867992
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
